Co-infection with hepatitis B and human immunodeficiency virus: epidemiology, pathogenesis, and treatment [0.03%]
乙型肝炎和人类免疫缺陷病毒共感染：流行病学、病理机制及治疗措施
Yaozu He,Weiyin Lin,Fei Gu et al.
Yaozu He et al.
Co-infection with hepatitis B virus (HBV) and human immunodeficiency virus (HIV) is common as the modes of disease transmission are similar. HIV affects the development of chronic HBV infection, leading to higher HBV DNA levels, cirrhosis, ...
Characteristics and risk factors of acquired drug resistance among people living with HIV: A retrospective study in Guangzhou, China (2018-2023) [0.03%]
广州市艾滋病患者获得性耐药的特征及危险因素（2018-2023）回顾性研究
Shiyun Lv,Quanmin Li,Weiyin Lin et al.
Shiyun Lv et al.
Background: Acquired drug resistance (ADR) in people living with HIV (PLWH) reduces treatment efficacy, restricts drug options, and increases the risk of human immunodeficiency virus (HIV) transmission. The resistance cha...
Correlation between IL-18 secretion by peripheral blood mononuclear cells and NK cells activation after SARS-CoV-2 booster vaccination in HIV-1-infected individuals [0.03%]
HIV-1感染者接种新冠病毒疫苗后的外周血单个核细胞分泌IL-18与NK细胞活化之间的相关性研究
Xiuwen Wang,Xiaodong Yang,Xin Zhang et al.
Xiuwen Wang et al.
Immune reconstitution inflammatory syndrome presenting as genital ulcers due to herpes simplex virus: A case report [0.03%]
免疫重建炎性综合征表现为由单纯疱疹病毒引起的生殖器溃疡的1例报告
Xin Zhang,Zhiqiang Mi,Xiaoyan Li et al.
Xin Zhang et al.
Immune reconstitution inflammatory syndrome (IRIS) is a collection of inflammatory disorders characterized by the paradoxical worsening of preexisting infections processes following the initiation of antiretroviral therapy in human immunode...
AIDS, crisis and power to transform (Text extract): UNAIDS global AIDS update 2025 (Executive Summary) [0.03%]
与艾滋病同行：危机中的变革力量（文本摘要）：联合国艾滋病规划署《2025年全球艾滋病报告》（概要）
Joint United Nations Programme on HIV/AIDS
Joint United Nations Programme on HIV/AIDS
Xiangxing Jin,Lili Ren,Xianwen Ren et al.
Xiangxing Jin et al.
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has significantly burdened global public health. However, the tropism of SARS-CoV-2 within the human body remains not ...
Viral persistence in long COVID: Research advances and treatment strategies [0.03%]
长期新冠中的病毒持续感染：研究进展与治疗策略
Shiyang Liu,Yuming Guo,Fu-Sheng Wang
Shiyang Liu
Although the coronavirus disease 2019 (COVID-19) pandemic has ended, the enduring health impacts of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection continue to garner global attention, as approximately 10% of patients...
From viral persistence to lipid imbalance: Immunological drivers of dyslipidemia in HIV [0.03%]
从病毒持续感染到脂质代谢失衡：HIV患者血脂异常的免疫驱动因素
Xin Huang,Wei Cao
Xin Huang
HBsAg loss in HIV/HBV coinfected patients: Hepatitis B cure insights and implications [0.03%]
人类免疫缺陷病毒/乙型肝炎病毒共感染患者中乙肝表面抗原清除的意义及影响：治愈洞察
Suling Chen,Guichan Liao,Haiming Yan et al.
Suling Chen et al.
HIV (human immunodeficiency virus)/HBV (hepatitis B virus) coinfection remains a significant public health challenge. HIV infection affects the natural course of chronic HBV infection, with HIV/HBV coinfected patients experiencing higher li...
Rongling Zhang,Xiaoying Gu,Hui Zhang et al.
Rongling Zhang et al.
Long coronavirus disease (COVID) is defined as the continuation or development of new symptoms three months after the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and that last for at least two months, with no oth...